SLRN Market Cap History Table | ||||||||
Also see: SLRN Shares Outstanding History and SLRN YTD Return |
SLRN Market Cap History Table | ||||||||
Also see: SLRN Shares Outstanding History and SLRN YTD Return |
SLRN Market Cap History Chart | |||||||||
-125.62% CAGR Mouse over chart for data details
|
SLRN Stock Price Chart |
About ACELYRIN Inc |
ACELYRIN is engaged in the identification, acquisition, development and commercialization of medicines for autoimmune and inflammatory diseases. Co.'s clinical and preclinical stage product candidates consisting of: izokibep, which is a small protein therapeutic designed to inhibit anti-interleukin-17A; lonigutamab, which is a humanized immunoglobulin G1 (IgG1) monoclonal antibody against insulin-like growth factor 1 receptor for the treatment of chronic urticaria; and SLRN-517, which is a fully human IgG1 monoclonal antibody targeting c-KIT for the treatment of chronic urticaria. We show 3 historical shares outstanding datapoints in our SLRN shares outstanding history coverage, used to compute SLRN market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SLRN market cap history over the course of time is important for investors interested in comparing SLRN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SLRN versus a peer is one thing; comparing SLRN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SLRN can fluctuate over the course of history. With this page we aim to empower investors researching SLRN by allowing them to research the SLRN market cap history. |
SLRN Current Stock Quote |
Free SLRN Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
SLRN Share Performance |
Market Cap Peers |
ACELYRIN (SLRN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
SLRX Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.